MLANA/MART1 Polyclonal Antibody, APC-Cy5 Conjugated-bs-0051R-APC-Cy5
Description
:APC-Cy5;host:Rabbit;target_protein:MLANA/MART1;modification:Unmodified;clonality:Polyclonal;isotype:IgG;concentration:1ug/ul;subcellular_locations:Cytoplasm, Cell membrane;source:KLH conjugated synthetic peptide derived from human MLANA/MART1;gene_id:2315;swiss_prot:Q16655;applications_with_dilutions:IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200);cross_reactive_species:Human;predicted_cross_reactive_species:;background:Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.;purification:Purified by Protein A.;storage_buffer:Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.;storage_condition:Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.;:650nm/670nm;synonyms:MART1; MART-1; Melanoma antigen recognized by T-cells 1; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A; MLANA